Survey

CSER Phase 2 Patient Reported Utility (PRU) of Clinical Sequencing Survey

Author(s):

Clinical Sequence Evidence-Generating Research (CSER Phase 2) Consortium

Year:

2019

The Patient Reported Utility (PRU) of Clinical Sequencing Survey asks participants to rate how useful they find nineteen outcomes of genome sequencing on a scale ranging from 1 (not at all useful) to 7 (extremely useful).

Research Population:

Adults
Parents

Return to Search Results

Share

View online source

Related Research Tools

Software

My46: A Web-based Tool for Self-guided Management of Genomic Test Results

Tabor and colleagues developed My46, a self-guided, web-based information management system for individuals undergoing genetic testing in clinical…

Survey

CSER Phase 2 Organizational Readiness to Change Assessment

The CSER Organizational Readiness to Change Assessment measures the readiness of healthcare systems to implement clinical sequencing. It is…

Survey

CSER Phase 2 Organizational Readiness to Change Assessment

The CSER Organizational Readiness to Change Assessment measures the readiness of healthcare systems to implement clinical sequencing. It is…

+ Search results